LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 254 of 497
Next
>>
>
6326 to 6350 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MCF7	Momelotinib	0.04	uM	LJP5	2	P12	72	hr	1235	3883	4156	0.9343	0.9065
MCF7	Momelotinib	0.04	uM	LJP5	3	P12	72	hr	1235	4488	4156	1.0798	1.1136
MCF7	Dasatinib	0.04	uM	LJP5	1	D06	72	hr	1235	2903	4156	0.6985	0.5710
MCF7	Dasatinib	0.04	uM	LJP5	2	D06	72	hr	1235	2660	4156	0.6400	0.4878
MCF7	Dasatinib	0.04	uM	LJP5	3	D06	72	hr	1235	2301	4156	0.5536	0.3648
MCF7	Dasatinib	0.04	uM	LJP6	1	I06	72	hr	1235	1192	4156	0.2868	-0.0149
MCF7	Dasatinib	0.04	uM	LJP6	2	I06	72	hr	1235	1074	4156	0.2584	-0.0553
MCF7	Dasatinib	0.04	uM	LJP6	3	I06	72	hr	1235	1116	4156	0.2685	-0.0409
MCF7	Dovitinib	0.04	uM	LJP5	1	E24	72	hr	1235	3629	4156	0.8732	0.8195
MCF7	Dovitinib	0.04	uM	LJP5	2	E24	72	hr	1235	3764	4156	0.9056	0.8657
MCF7	Dovitinib	0.04	uM	LJP5	3	E24	72	hr	1235	4146	4156	0.9976	0.9965
MCF7	Enzastaurin	0.04	uM	LJP5	1	D18	72	hr	1235	4265	4156	1.0262	1.0373
MCF7	Enzastaurin	0.04	uM	LJP5	2	D18	72	hr	1235	3868	4156	0.9307	0.9013
MCF7	Enzastaurin	0.04	uM	LJP5	3	D18	72	hr	1235	3977	4156	0.9569	0.9387
MCF7	Erlotinib	0.04	uM	LJP5	1	M24	72	hr	1235	3403	4156	0.8188	0.7421
MCF7	Erlotinib	0.04	uM	LJP5	2	M24	72	hr	1235	3534	4156	0.8503	0.7870
MCF7	Erlotinib	0.04	uM	LJP5	3	M24	72	hr	1235	3468	4156	0.8344	0.7644
MCF7	Foretinib	0.04	uM	LJP5	1	H12	72	hr	1235	3940	4156	0.9480	0.9260
MCF7	Foretinib	0.04	uM	LJP5	2	H12	72	hr	1235	4240	4156	1.0202	1.0287
MCF7	Foretinib	0.04	uM	LJP5	3	H12	72	hr	1235	4477	4156	1.0772	1.1098
MCF7	R406	0.04	uM	LJP6	1	C18	72	hr	1235	3877	4156	0.9328	0.9044
MCF7	R406	0.04	uM	LJP6	2	C18	72	hr	1235	4413	4156	1.0618	1.0879
MCF7	R406	0.04	uM	LJP6	3	C18	72	hr	1235	4030	4156	0.9696	0.9568
MCF7	Pictilisib	0.04	uM	LJP6	1	D24	72	hr	1235	1636	4156	0.3936	0.1372
MCF7	Pictilisib	0.04	uM	LJP6	2	D24	72	hr	1235	1706	4156	0.4105	0.1611

|<
<<
Previous
Page 254 of 497
Next
>>
>
6326 to 6350 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)